메뉴 건너뛰기




Volumn 140, Issue 3, 2011, Pages 791-798.e2

Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis

Author keywords

CYP2C19; Drug Interactions; Plavix; Proton Pump Inhibitor

Indexed keywords

AMOXICILLIN; ANTACID AGENT; BISMUTH CITRATE; CLARITHROMYCIN; CLOPIDOGREL; ESOMEPRAZOLE; METRONIDAZOLE; TETRACYCLINE;

EID: 79952296065     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.11.056     Document Type: Article
Times cited : (85)

References (23)
  • 2
    • 0035899289 scopus 로고    scopus 로고
    • Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
    • DOI 10.1056/NEJMoa010746
    • S. Yusuf, F. Zhao, and S.R. Mehta Effects of clopidogrel in addition to aspirin in patients with acute coronary syndrome without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
    • (2001) New England Journal of Medicine , vol.345 , Issue.7 , pp. 494-502
    • Yusuf, S.1    Zhao, F.2    Mehta, S.R.3    Chrolavicius, S.4    Tognoni, G.5    Fox, K.K.6
  • 3
    • 33645861080 scopus 로고    scopus 로고
    • CHARISMA Investigators: Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
    • D.L. Bhatt, K.A. Fox, and W. Hacke ; CHARISMA Investigators Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
    • (2006) N Engl J Med , vol.354 , pp. 1706-1717
    • Bhatt, D.L.1    Fox, K.A.2    Hacke, W.3
  • 4
    • 0030590746 scopus 로고    scopus 로고
    • A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE)
    • CAPRIE Steering Committee
    • CAPRIE Steering Committee A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE) Lancet 348 1996 1329 1339
    • (1996) Lancet , vol.348 , pp. 1329-1339
  • 5
    • 70449341011 scopus 로고    scopus 로고
    • ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction
    • J.L. Anderson, C.D. Adams, and E.M. Antman ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction Circulation 116 2007 e138 e304
    • (2007) Circulation , vol.116
    • Anderson, J.L.1    Adams, C.D.2    Antman, E.M.3
  • 9
    • 77954825680 scopus 로고    scopus 로고
    • Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapy
    • C.H. Kuo, S.S. Wang, and W.H. Hsu Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapy Helicobacter 15 2010 265 272
    • (2010) Helicobacter , vol.15 , pp. 265-272
    • Kuo, C.H.1    Wang, S.S.2    Hsu, W.H.3
  • 10
    • 0036291686 scopus 로고    scopus 로고
    • Risk factors of ulcer development in patients with non-ulcer dyspepsia: A prospective 2-year follow-up study of 209 patients
    • P.I. Hsu, K.H. Lai, and G.H. Lo Risk factors of ulcer development in patients with non-ulcer dyspepsia: a prospective 2-year follow-up study of 209 patients Gut 51 2002 15 20
    • (2002) Gut , vol.51 , pp. 15-20
    • Hsu, P.I.1    Lai, K.H.2    Lo, G.H.3
  • 12
    • 0015278355 scopus 로고
    • Laboratory tests of platelet function
    • H.J. Day, and H. Holmsen Laboratory tests of platelet function Ann Clin Lab Sci 2 1972 63 74
    • (1972) Ann Clin Lab Sci , vol.2 , pp. 63-74
    • Day, H.J.1    Holmsen, H.2
  • 13
    • 33745610044 scopus 로고    scopus 로고
    • Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications
    • K.C. Lai, K.M. Chu, and W.M. Hui Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications Clin Gastroenterol Hepatol 4 2006 860 865
    • (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 860-865
    • Lai, K.C.1    Chu, K.M.2    Hui, W.M.3
  • 14
    • 0034048238 scopus 로고    scopus 로고
    • Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers: A gastroscopic study
    • F.T. Fork, P. Lafolie, and E. Toth Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers: a gastroscopic study Scand J Gastroenterol 35 2000 464 469 (Pubitemid 30354084)
    • (2000) Scandinavian Journal of Gastroenterology , vol.35 , Issue.5 , pp. 464-469
    • Fork, F.-T.1    Lafolie, P.2    Toth, E.3    Lindgarde, F.4
  • 16
    • 73849084548 scopus 로고    scopus 로고
    • Proton pump inhibitor and clopidogrel interaction: Fact or fiction?
    • L. Laine, and C. Hennekens Proton pump inhibitor and clopidogrel interaction: fact or fiction? Am J Gastroenterol 105 2010 34 41
    • (2010) Am J Gastroenterol , vol.105 , pp. 34-41
    • Laine, L.1    Hennekens, C.2
  • 17
    • 38349065084 scopus 로고    scopus 로고
    • Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: The randomized double-blind OCLA (Omeprazole Clopidogrel Asprin) study
    • M. Gilard, B. Arnaud, and J.C. Cornily Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized double-blind OCLA (Omeprazole Clopidogrel Asprin) study J Am Coll Cardiol 51 2008 256 260
    • (2008) J Am Coll Cardiol , vol.51 , pp. 256-260
    • Gilard, M.1    Arnaud, B.2    Cornily, J.C.3
  • 18
    • 61549124132 scopus 로고    scopus 로고
    • Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome
    • P.M. Ho, T.M. Moddox, and L. Wang Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome JAMA 301 2009 937 944
    • (2009) JAMA , vol.301 , pp. 937-944
    • Ho, P.M.1    Moddox, T.M.2    Wang, L.3
  • 19
    • 62649164844 scopus 로고    scopus 로고
    • A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
    • D. Juurling, T. Gomes, and D.T. Ko A population-based study of the drug interaction between proton pump inhibitors and clopidogrel CMAJ 180 2009 713 718
    • (2009) CMAJ , vol.180 , pp. 713-718
    • Juurling, D.1    Gomes, T.2    Ko, D.T.3
  • 20
    • 77955452982 scopus 로고    scopus 로고
    • Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: The clopidogrel medco outcome study
    • R.P. Kreutz, E.J. Stanek, and R. Aubert Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel medco outcome study Pharmacotherapy 30 2010 787 796
    • (2010) Pharmacotherapy , vol.30 , pp. 787-796
    • Kreutz, R.P.1    Stanek, E.J.2    Aubert, R.3
  • 21
    • 78149487926 scopus 로고    scopus 로고
    • Clopidogrel with or without omeprazole in coronary artery disease
    • D.L. Bhatt, B.L. Cryer, and C.F. Contant Clopidogrel with or without omeprazole in coronary artery disease N Engl J Med 363 2010 1909 1917
    • (2010) N Engl J Med , vol.363 , pp. 1909-1917
    • Bhatt, D.L.1    Cryer, B.L.2    Contant, C.F.3
  • 22
    • 64849087438 scopus 로고    scopus 로고
    • Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel
    • D. Sibbing, T. Morath, and J. Stegherr Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel Thromb Haemost 101 2009 714 719
    • (2009) Thromb Haemost , vol.101 , pp. 714-719
    • Sibbing, D.1    Morath, T.2    Stegherr, J.3
  • 23
    • 58749094444 scopus 로고    scopus 로고
    • Cytochrome P-450 and response to clopidogrel
    • J.L. Mega, S.L. Close, and S.D. Wiviott Cytochrome P-450 and response to clopidogrel N Engl J Med 360 2009 354 362
    • (2009) N Engl J Med , vol.360 , pp. 354-362
    • Mega, J.L.1    Close, S.L.2    Wiviott, S.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.